A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer

Y. J. Bang, Y. K. Kang, M. Ng, H. C. Chung, Z. A. Wainberg, S. Gendreau, W. Y. Chan, N. Xu, D. Maslyar, R. Meng, I. Chau, J. A. Ajani

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A phase II, randomised study of mFOLFOX6 with or without the Akt inhibitor ipatasertib in patients with locally advanced or metastatic gastric or gastroesophageal junction cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences